Objective: To measure the acceptance of a coronavirus disease 2019 (COVID-19) vaccine among the sector of the oil company adult population in Kuwait and assess its determinants. Subjects and Methods: A cross-sectional email study enrolled adults working for Kuwait oil companies (n = 1689; aged ≥21 years). Acceptance of a COVID-19 vaccine was considered if participants selected the options and received the vaccine, definitely or probably will accept vaccination against COVID-19 once a vaccine is available.” A modified Poisson regression was used to investigate the associations and calculate the adjusted prevalence ratios (aPRs) and their 95% confidence intervals (CIs). Results: In total, 92.5% (1563/1689) of the participants were willing to accept COVID-19 vaccines once available. No difference in sex was observed in the willingness to accept a COVID-19 vaccine (92.5 vs. 92%, p 0.5). Responders who believed vaccines in general to have health-related risks were less likely to get vaccinated (aPR = 0.39, 95% CI: 0.35 - 0.44). In addition, participants who received the influenza vaccine were more willing to have a COVID-19 vaccine (aPR = 1.44, 95% CI: 1.31 - 1.58). Acceptance of the vaccine against COVID-19 increased as the self-perceived chances of contracting the infection increased (p < 0.001). Conclusion: Overall, 92.5% of the study participants demonstrated a willingness to be vaccinated against COVID-19. However, we found that public health authorities should address several factors influencing the level of acceptance.
References
[1]
World Health Organization (2020) Coronavirus Disease 2019 (Covid-19): Situation Report, 51. World Health Organization, Geneva. https://apps.who.int/iris/handle/10665/331475
[2]
World Health Organization (2020) Draft Landscape of COVID-19 Candidate Vaccines. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines
[3]
MacDonald, N.E. and SAGE Working Group on Vaccine Hesitancy (2015) Vaccine Hesitancy: Definition, Scope and Determinants. Vaccine, 33, 4161-4164. https://doi.org/10.1016/j.vaccine.2015.04.036
[4]
Biasio, L.R., Bonaccorsi, G., Lorini, C. and Pecorelli, S. (2021) Assessing COVID-19 Vaccine Literacy: A Preliminary Online Survey. Human Vaccines & Immunotherapeutics, 17, 1304-1312. https://doi.org/10.1080/21645515.2020.1829315
[5]
Wong, L.P., Alias, H., Wong, P.F., Lee, H.Y. and AbuBakar, S. (2020) The Use of the Health Belief Model to Assess Predictors of Intent to Receive the Covid-19 Vaccine and Willingness to Pay. Human Vaccines & Immunotherapeutics, 16, 2204-2214. https://doi.org/10.1080/21645515.2020.1790279
[6]
Malik, A.A., McFadden, S.M., Elharake, J. and Omer, S.B. (2020) Determinants of Covid-19 Vaccine Acceptance in the US. EClinicalMedicine, 26, 100495. https://doi.org/10.1016/j.eclinm.2020.100495
[7]
Alqudeimat, Y., Alenezi, D., AlHajri, B., Alfouzan, H., Almokhaizeem, Z., Altamimi, S., Almansouri, W., Alzalzalah, S. and Ziyab, A.H. (2021) Acceptance of a COVID-19 Vaccine and Its Related Determinants among the General Adult Population in Kuwait. Medical Principles and Practice, 30, 262-271. https://doi.org/10.1159/000514636
[8]
Reiter, P.L., Pennell, M.L. and Katz, M.L. (2020) Acceptability of a Covid-19 Vaccine among Adults in the United States: How Many People Would Get Vaccinated? Vaccine, 38, 6500-6507. https://doi.org/10.1016/j.vaccine.2020.08.043
[9]
Neumann-Bohme, S., Varghese, N.E., Sabat, I., Barros, P.P., Brouwer, W., van Exel, J., et al. (2020) Once We Have It, Will We Use It? A European Survey on Willingness to Be Vaccinated against Covid-19. The European Journal of Health Economics, 21, 977-982. https://doi.org/10.1007/s10198-020-01208-6
